Investing
Cathie Wood's ARK Invest Buys Nearly 475,000 Shares of Signify Health
Published:
A couple ARK Invest exchange-traded funds run by ETF star Cathie Wood bought nearly 475,000 shares of Signify Health Inc. (NYSE: SGFY) on Tuesday, as the price of these funds were up more than 5% in Tuesday’s session. These funds had only turned negative recently in their performance over the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 160,234 shares of Signify Health, and ARK Innovation ETF (NYSEARCA: ARKK) added 313,766 shares. At Tuesday’s closing price, this would have valued thes purchases at roughly $7.2 million. This is only a small fraction of the total holdings. The Genomic Revolution fund is down 32% over the past 52 weeks, and the other is down nearly 16% in the same time.
Check out all the ARK Invest trades for Tuesday:
| Fund | Direction | Ticker | Name | Shares |
|---|---|---|---|---|
| ARKF | Buy | DSYSJ | DISCOVERY | 55,621 |
| ARKG | Buy | SGFY | SIGNIFY HEALTH | 160,234 |
| ARKG | Sell | TAK | TAKEDA PHARMACEUTICAL | 846,189 |
| ARKK | Buy | SGFY | SIGNIFY HEALTH | 313,766 |
| ARKK | Buy | TDOC | TELADOC HEALTH | 63,567 |
| ARKK | Sell | EDIT | EDITAS MEDICINE | 138,796 |
| ARKQ | Buy | BLDE | BLADE AIR MOBILITY | 11,926 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
24/7 Wall St.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
